Details of issuance or disposal
Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price)
Number of shares delivered during the month: 740,000 shares (740,000 new shares; 0 treasury shares transferred)
The lower thin line represents the existing number of shares to which these shares will be added.
Exercise ratio during the month: 2.31% (as a percentage of the total 320,000 rights issued) / Exercise ratio subject to exercise restrictions: 1.58%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 740,000 shares (740,000 new shares; 0 treasury shares transferred) |
| Intended allottee | EVO FUND (issued on 14 April 2025) |
| Dilution Rate | Exercise ratio during the month: 2.31% (as a percentage of the total 320,000 rights issued) / Exercise ratio subject to exercise restrictions: 1.58% |
| Total number of issued shares | 75,495,300 shares (as of the end of the month preceding the target month, including 31,656 treasury shares) → Not disclosed |
| Exercise price | Exercise price during the month: ¥36 or ¥37 (initial exercise price at issuance and adjustment floor: not disclosed) |
| Number of Stock Acquisition Rights | Total issued: 320,000 rights; unexercised as of 31 March 2026: 32,000 rights; unexercised as of the end of April 2026: 24,600 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing Issued on 14 April 2025 / Type 18th Stock Acquisition Rights with provisions for adjustment of the exercise price, allotted to EVO FUND / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for April 2026.